文献速递自身炎症与 IgG4 相关病

IgG4相关自身免疫性胰腺炎的胰腺损伤与症状负担定义:来自单中心注册队列118例患者的横断面研究

Defining pancreatic damage and symptom burden in IgG4-related autoimmune pancreatitis: A cross-sectional study of 118 patients from a single-center registry.
PubMed 文献 · Semin Arthritis Rheum · 2025-05-21

该研究对符合ACR/EULAR IgG4-RD分类标准的303例患者进行横断面分析,其中118例(39%)存在自身免疫性胰腺炎。自身免疫性胰腺炎患者中糖尿病、外源性胰腺功能不全或两者兼有者分别占47%、48%和21%,鼓励检测粪便弹性蛋白酶后49份样本中40份(82%)浓度降低。患者报告腹痛、体重下降和粪便改变负担高于无胰腺炎者。

要点

  • 303例符合分类标准患者中118例(39%)有自身免疫性胰腺炎证据。
  • 自身免疫性胰腺炎患者中糖尿病47%、外源性胰腺功能不全48%、两者兼有21%。
  • 鼓励检测后49份粪便中40份(82%)弹性蛋白酶浓度降低。

核心结论

  • 尽管自身免疫性胰腺炎常表现为亚临床过程,但相当高比例的IgG4-RD患者合并外源性胰腺功能不全、糖尿病或两者兼有。
  • 有症状的急性胰腺炎可能并不常见,但患者报告的由IgG4相关自身免疫性胰腺炎或其并发症导致的症状负担高于既往认识。

研究设计与样本

  • 对符合ACR/EULAR IgG4-RD分类标准的患者进行横断面分析,通过病历回顾收集疾病特征和并发症,并向所有患者发放关于症状和疾病史的问卷调查。
  • 在病历回顾时符合分类标准的303例患者中,118例(39%)有自身免疫性胰腺炎证据。
  • 162/325(50%)完成问卷,其中81例(50%)有自身免疫性胰腺炎。

主要发现

  • 自身免疫性胰腺炎患者中,急性胰腺炎的明显指标(如腹痛、恶心/呕吐、血清脂肪酶升高)各自出现在不足50%的患者中。
  • 自身免疫性胰腺炎患者中糖尿病、外源性胰腺功能不全或两者兼有的比例分别为47%、48%和21%。
  • 鼓励所有患者检测粪便弹性蛋白酶后,40/49(82%)份粪便样本弹性蛋白酶浓度降低。
  • 9/118(8%)在诊断明确前已接受胰腺切除术。
  • 有自身免疫性胰腺炎的患者报告腹痛、体重下降和粪便改变的负担高于无自身免疫性胰腺炎者(均p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Type 1 autoimmune pancreatitis is a common manifestation of IgG4-related disease (IgG4-RD). However, there is a paucity of literature characterizing pancreatic damage and symptom burden in IgG4-RD. METHODS: We performed a cross-sectional analysis of patients who fulfilled the ACR/EULAR IgG4-RD Classification Criteria. Disease features and complications were collected by medical record review. A survey regarding symptoms and disease history was distributed to all patients. Characteristics were compared between patients with and without autoimmune pancreatitis. RESULTS: Of 303 patients who fulfilled Classification Criteria at the time of the chart review, 118 (39 %) had evidence of autoimmune pancreatitis. Overt indicators of acute pancreatitis (e.g., abdominal pain, nausea/emesis, elevated serum lipase) each occurred in fewer than 50 % of patients with autoimmune pancreatitis. Diabetes mellitus (DM), exocrine pancreatic insufficiency (EPI), or both were present in 47 %, 48 %, and 21 % of the autoimmune pancreatitis patients, respectively. After encouraging all patients to have fecal elastase measured, 40/49 (82 %) stool samples had low elastase concentrations. 9/118 (8 %) had undergone pancreatic resections before the diagnosis was established. 162/325 (50 %) completed surveys (n = 81 [50 %] with autoimmune pancreatitis). Patients with autoimmune pancreatitis reported a higher burden of abdominal pain, weight loss, and changes in stool than those without (all p < 0.05). CONCLUSION: Despite an often subclinical presentation, autoimmune pancreatitis is associated with EPI, DM, or both in a high percentage of patients with IgG4-RD. While symptomatic acute pancreatitis may not be common, patient-reported symptom burden due to IgG4-related autoimmune pancreatitis or its complications is greater than previously appreciated.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Katz G, Harvey L, Hernandez-Barco YG, et al. Defining pancreatic damage and symptom burden in IgG4-related autoimmune pancreatitis: A cross-sectional study of 118 patients from a single-center registry. Semin Arthritis Rheum. 2025. PMID: 40403524. doi:10.1016/j.semarthrit.2025.152742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。